文献速递白血病

T细胞急性淋巴细胞白血病中PI3K信号调控:新型PTEN/Ikaros/miR-26b机制揭示PIK3CD的关键可靶向作用

Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
PubMed 文献 · Leukemia · 2017-03-10

本研究在Pten缺陷小鼠T-ALL模型中鉴定miR-26b表达下调,并验证其在小鼠和人T-ALL细胞中降低;外源性miR-26b可抑制T-ALL细胞增殖、促进凋亡并阻碍体内进展。机制上miR-26b直接靶向PIK3CD抑制PI3K/AKT通路,PTEN通过调节Ikaros亚型差异表达诱导miR-26b,提示miR-26b在T-ALL中发挥抑癌作用。

要点

  • miR-26b在小鼠和人T-ALL细胞中表达降低。
  • 外源性miR-26b抑制T-ALL细胞增殖、促进凋亡并阻碍体内进展。
  • miR-26b直接靶向PIK3CD抑制PI3K/AKT通路,PTEN通过Ikaros亚型调控miR-26b。

核心结论

  • 结果提示miR-26b在T-ALL发生中发挥抑癌作用。
  • 进一步表征miR-26b的靶点和调控因子可能有助于开发新疗法。

研究设计与样本

  • 研究在Pten缺陷小鼠T-ALL模型中分析miRNA谱,鉴定miR-26b为潜在失调基因。
  • 在体外使用小鼠和人T-ALL细胞验证miR-26b表达及外源性miR-26b的功能。
  • 在人T-ALL细胞系中验证miR-26b对PIK3CD的靶向作用及PIK3CD抑制的效果。

主要发现

  • miR-26b在小鼠和人T-ALL细胞中表达降低。
  • 外源性miR-26b在体外降低T-ALL细胞增殖并促进凋亡,在体内阻碍T-ALL进展。
  • miR-26b通过直接靶向PIK3CD(编码PI3Kδ)抑制人T-ALL细胞系中的PI3K/AKT通路。
  • PIK3CD的shRNA和PIK3CD抑制剂CAL-101降低T-ALL细胞生长并增加凋亡。
  • PTEN通过调控Ikaros亚型的差异表达诱导miR-26b,Ikaros亚型是miR-26b的转录调控因子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy, and T-ALL patients are prone to early disease relapse and suffer from poor outcomes. The PTEN, PI3K/AKT and Notch pathways are frequently altered in T-ALL. PTEN is a tumor suppressor that inactivates the PI3K pathway. We profiled miRNAs in Pten-deficient mouse T-ALL and identified miR-26b as a potentially dysregulated gene. We validated decreased expression levels of miR-26b in mouse and human T-ALL cells. In addition, expression of exogenous miR-26b reduced proliferation and promoted apoptosis of T-ALL cells in vitro, and hindered progression of T-ALL in vivo. Furthermore, miR-26b inhibited the PI3K/AKT pathway by directly targeting PIK3CD, the gene encoding PI3Kδ, in human T-ALL cell lines. ShRNA for PIK3CD and CAL-101, a PIK3CD inhibitor, reduced the growth and increased apoptosis of T-ALL cells. Finally, we showed that PTEN induced miR-26b expression by regulating the differential expression of Ikaros isoforms that are transcriptional regulators of miR-26b. These results suggest that miR-26b functions as a tumor suppressor in the development of T-ALL. Further characterization of targets and regulators of miR-26b may be promising for the development of novel therapies.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Yuan T, Yang Y, Chen J, et al. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia. 2017. PMID: 28280276. doi:10.1038/leu.2017.80

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。